AMINOGLYCOSIDE PHARMACOKINETICS - VOLUME OF DISTRIBUTION IN SPECIFIC ADULT PATIENT SUBGROUPS

被引:35
作者
DAGER, WE [1 ]
机构
[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,SAN FRANCISCO,CA 94143
关键词
D O I
10.1177/106002809402800719
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review the published clinical studies reporting volume of distribution for aminoglycosides in patient population subgroups. Controversies in methods used are discussed. DATA SOURCES: National Library of Medicine Medlars, searched using MEDLINE. STUDY SELECTION: Published articles primarily relating to pharmacokinetic properties of aminoglycosides in specific adult patient subgroups published within the past 20 years were included. Pediatric studies were excluded. DATA EXTRACTION: The methodology, assay technique, and results from clinical studies reporting aminoglycoside volume of distribution were evaluated. DATA SYNTHESIS: Clinical studies reporting aminoglycoside volume of distribution subgroups, including the methods by which their results were derived, are tabulated. CONCLUSIONS: The expected aminoglycoside volume of distribution can vary, depending on a patient's clinical presentation. Data presented will allow a more refined initial estimation of volumes of distribution, which may facilitate the achievement of desired aminoglycoside serum concentrations.
引用
收藏
页码:944 / 951
页数:8
相关论文
共 40 条
[1]   AMIKACIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS [J].
BAUER, LA ;
BLOUIN, RA ;
GRIFFEN, WO ;
RECORD, KE ;
BELL, RM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (04) :519-522
[2]   OPTIMIZATION OF PHARMACOKINETIC MONITORING .1. LINEAR PHARMACOKINETICS [J].
BERG, MJ ;
LANTZ, RK ;
SCHOENWALD, RD ;
CLARKE, MI ;
SCHOTTELIUS, DD .
THERAPEUTIC DRUG MONITORING, 1983, 5 (04) :379-387
[3]   GENTAMICIN PHARMACOKINETICS IN PATIENTS WITH MALIGNANCIES [J].
BERTINO, JS ;
BOOKER, LA ;
FRANCK, P ;
RYBICKI, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) :1501-1503
[4]   COMPARISON OF GENTAMICIN IMMUNOASSAYS USING UNIVARIATE AND MULTIVARIATE ANALYSES [J].
BOYCE, EG ;
LAWSON, LA ;
GIBSON, GA ;
NACHAMKIN, I .
THERAPEUTIC DRUG MONITORING, 1989, 11 (01) :97-104
[5]  
BOYCE EG, 1989, CLIN PHARMACY, V8, P48
[6]  
CARR MR, 1988, SURGERY, V103, P533
[7]   VALIDATION OF THE USE OF BAYESIAN-ANALYSIS IN THE OPTIMIZATION OF GENTAMICIN THERAPY FROM THE COMMENCEMENT OF DOSING [J].
CHRYSTYN, H .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (01) :49-53
[8]   AMIKACIN PHARMACOKINETICS IN PATIENTS RECEIVING HIGH-DOSE CANCER-CHEMOTHERAPY [J].
DAVIS, RL ;
LEHMANN, D ;
STIDLEY, CA ;
NEIDHART, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (05) :944-947
[9]   VARIATION IN THE PHARMACOKINETICS OF GENTAMICIN AND TOBRAMYCIN IN PATIENTS WITH PLEURAL EFFUSIONS AND HYPOALBUMINEMIA [J].
ETZEL, JV ;
NAFZIGER, AN ;
BERTINO, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :679-681
[10]  
FRANSEN TR, 1987, JPEN J PARENTER ENTE, V51, P77